Elevance Health Inc(ELV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 18.76 | EPS (ttm) | 23.46 | Insider Own | 0.23% | Shs Outstand | 216.1M | Perf Week | 2.73% |
| Market Cap | 95.05B | Forward P/E | 14.57 | EPS next Y | 4.53% | Insider Trans | -1.76% | Shs Float | 215.6M | Perf Month | 10.47% |
| Enterprise Value | - | PEG | 3.22 | EPS next Q | 2.1 | Inst Own | 95.08% | Short Float | 2.25% | Perf Quarter | 16.28% |
| Income | 5.14B | P/S | 0.47 | EPS this Y | -4.64% | Inst Trans | 0.73% | Short Ratio | 4.23 | Perf Half Y | 27.61% |
| Sales | 201.83B | P/B | 2.13 | EPS next 5Y | 4.53% | ROA | 4.1% | Short Interest | 4.85M | Perf YTD | 25.5% |
| Book/sh | 206.75 | P/C | - | EPS past 3/5Y | 1.27% 6.99% | ROE | 11.6% | 52W High | -2.38% ($450.69) | Perf Year | 27.05% |
| Cash/sh | - | P/FCF | 14.59 | Sales past 3/5Y | 8.34% 10.32% | ROIC | 6.85% | 52W Low | 60.07% ($274.84) | Perf 3Y | -2.62% |
| Dividend Est. | $6.86 (1.56%) | EV/EBITDA | - | EPS Y/Y TTM | -4.06% | Gross Margin | - | Volatility(W/M) | 3.25% 2.74% | Perf 5Y | 1.53% |
| Dividend TTM | 6.87 | EV/Sales | - | Sales Y/Y TTM | 3.6% | Oper. Margin | 3.81% | ATR (14) | 11.45 | Perf 10Y | 256.23% |
| Dividend Ex-Date | 2026/12/4 | Quick Ratio | - | EPS Q/Q | 18.02% | Profit Margin | 2.55% | RSI (14) | 66.29 | Recom | 1.88 |
| Dividend Gr. 3/5Y | 10.14% 12.47% | Current Ratio | 1.47 | Sales Q/Q | 1.42% | SMA20 | 6.28% ($413.95) | Beta | 0.64 | Target Price | $478.71 |
| Payout | 27.13% | Debt/Eq | 0.69 | Earnings | 2026/10/21 | SMA50 | 7.82% ($408.04) | Rel Volume | 1.02 | Prev Close | $445.28 |
| Employees | 97100 | LT Debt/Eq | 0.68 | EPS/Sales Surpr. | 48.28% 2.35% | SMA200 | 18.54% ($371.14) | Avg Volume(3M) | 1.15M | Price | $439.95 |
| IPO | 2001/10/30 | Option/Short | Yes/Yes | Trades | 22645 | Volume | 1,173,820 | Change | -1.2% |
🩺 A leading company in the U.S. health insurance and medical services industry. Headquartered in Indianapolis, Indiana, it is a comprehensive health insurance group that holds numerous Blue Cross·Blue Shield licenses and has operated an extensive member base alongside integrated medical services.
Over the past 1 year, on the higher side
2% below its 1-year high.
Traded about as much as usual. That is 102% of its average volume.
ELV has weak earning power
Of every $100 in sales, $3.81 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -4.6% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,457. Peers typically go for $1,761. It is about in line with its own 5-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +1.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.56% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 95.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #3 of 11 in the industry
Based on market cap of $95B.
FAQ
What kind of company is ELV?
ELV belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of ELV?
The market cap of ELV is approximately $95.1B, ranking 171 within its sector.
Does ELV pay dividends?
ELV has a dividend yield of approximately 1.56%, with an annual dividend of $6.86.
What is the P/E ratio of ELV?
ELV has a P/E ratio of approximately 18.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ELV?
ELV has recorded a 52-week high of $450.69 and a low of $274.84.